Pivotal trial of a biodegradable stent for patients with refractory benign esophageal stricture.

Tomonori YanoYusuke YodaSatoru NonakaSeiichiro AbeNoboru KawataToshiyuki YoshioTakashi SasakiShinwa TanakaFumisato SasakiTakao MaekitaMasayuki KitanoKenshi MatsumotoHiroyuki IsayamaHiroyuki Ono

Published in: Esophagus : official journal of the Japan Esophageal Society (2022)

The BDS was effective for refractory BES and the safety was acceptable. However, the indication for this procedure in patients RECEIVING CRT for esophageal cancer should be carefully considered.

Keyphrases

drug delivery
study protocol
clinical trial
phase iii
minimally invasive
randomized controlled trial
heart failure
left ventricular